The global butterfly needle sets market is witnessing significant expansion, driven by increasing chronic disease prevalence, advancements in medical technology, and growing demand for minimally ...

The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 ...

Four out of 10 people living with diabetes miss appointments due to shame1. How can we change that? A lot of things we ...

Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.

Danish biopharma giant Novo Nordisk (NOV: N) is breaking new ground with its GLP-1 agonist semaglutide, as a small mid-stage ...

Eden is providing access to a new way for individuals to explore GLP-1 therapy: a compounded semaglutide gummy, available ...

Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

Columnist Teri Sforza writes that childhood obesity in California is on the rise, state data shows. Free school meals have ...

Adjusted EBITDA margin increased to 37.2% from 25.2% in Q4 2024, driven by cost reductions and operational improvements. Management's tone shifted positively, highlighting stronger-than-expected ...